Plasma resilience: Europe’s lifeline — and why we must strengthen it now

Plasma Resilience: Europe's Lifeline

Human plasma, a protein-rich liquid making up 55% of our blood, is crucial for developing therapies for various conditions, including rare inherited disorders and immunodeficiencies.

Despite its importance, Europe's plasma supply chain is vulnerable, relying on donations from over 12 million people each year, governed by strict safety standards set by EU Member States and international organizations like the International Quality Plasma Program (IQPP) and the Plasma Protein Therapeutics Association (PPTA).

However, this is not enough, as nearly 40% of plasma used to make medicines for Europe must be imported from the United States.

Plasma is singularly human, existing only thanks to the generosity of real people, unlike many therapies that can be produced in a lab.

Autor's resume: Europe needs to strengthen plasma resilience now.

more

Euronews Euronews — 2025-10-16

More News